Dr. Rustin Dakota Carter, MD

Dr. Carter practices at Baptist Hospitals of Southeast Texas in Beaumont, Texas, part of Community Hospital Corporation.

Dr. Carter's NPI, 1770902306, was assigned on April 10, 2014. Dr. Carter graduated from McGovern Medical School in 2016. Dr. Carter holds California license A180786.

Dr. Carter's primary practice is Baptist Hospitals of Southeast Texas, at 3080 College Street, Beaumont, TX 77701 in Jefferson County. The practice phone is (409) 212-5000.

Dr. Carter's primary practice is Baptist Hospitals of Southeast Texas in Beaumont, Texas, part of Community Hospital Corporation. The medical group on file is Baptist Hospitals of Southeast Texas. Dmand AI also links Dr. Carter to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carter practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Carter's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Carter is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Carter's licenses on file in 15 states: California, Michigan, Colorado, Nevada, Arizona, Kentucky, Maryland, Pennsylvania, Texas, Virginia, Washington, Wyoming, Delaware, Georgia and Montana.

CMS data shows 949 Medicare services from Dr. Carter across 9 procedure codes in 2024, for 136 Medicare patients. Medicare paid $46,602 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Carter in 2024. The largest group is 75 to 84, with 52 patients. 75% of them have anxiety, and 75% have depression. 16% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carter's median patient age at 16, with 59% women.

In 2024, Dr. Carter wrote 281 Medicare Part D claims for 82 patients. 97% of them were for generic drugs. CMS names the drug for 168 of them, across 10 drugs with 11 or more claims each, at $2,424 in total drug cost. In 2023, CMS named 155 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Carter for performance year 2024, reported as part of a group. Dr. Carter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 18 general payments to Dr. Carter from 7 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $142.

Dr. Carter graduated from McGovern Medical School in 2016.

Dr. Carter is in network with 14 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.